Shalby share price

Balanced risk
  • 36%Low risk
  • 36%Moderate risk
  • 36%Balanced risk
  • 36%High risk
  • 36%Extreme risk
  • 191.15(-0.23%)
    May 14, 2025 15:29:48 PM IST
    • NSE
    • BSE
  • Vol : 67.15K (NSE + BSE)
    Last 20 day avg : 109.65 K

Shalby is trading -0.23% lower at Rs 191.15 as compared to its last closing price. Shalby has been trading in the price range of 192.35 & 188.70. Shalby has given -16.93% in this year & 5.81% in the last 5 days. Shalby has TTM P/E ratio 77.41 as compared to the sector P/E of 23.64.There are 1 analysts who have initiated coverage on Shalby. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -1.81 Crores in its last quarter.Listed peers of Shalby include Artemis Medicare Services (0.04%), Krsnaa Diagnostics (0.21%), Shalby (-0.23%).The Mutual Fund holding in Shalby was at -% in . The MF holding has - from the last quarter. The FII holding in Shalby was at 4.65% in 31 Dec 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on May 14, 2025, 09:33 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.64
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.02
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    63.44
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.95
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.38
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
188.70
Highest
192.35
52 week range
Lowest
177.25
Highest
325.00
Shalby Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue grew in December quarter by 27.58% from Rs 275.63 crore to Rs 216.05 crore, year-on-year
    • financial-insightsCompany has registered a loss of 1.81 cr vs a profit of 19.07 cr in the same quarter last year.
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Shalby Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 197.15
  • R2
  • 204.75
  • R3
  • 214.70
Pivot187.20
  • S1
  • 179.60
  • S2
  • 169.65
  • S3
  • 162.05
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Shalby Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Artemis Medicare Services
Bearish
248.050.043,435.0272.097.680.1863.85
Krsnaa Diagnostics
Bearish
685.950.212,211.8442.712.950.345.17
Shalby
Neutral
191.15-0.232,060.8424.082.020.6422.68
Dr. Agarwal's Eye Hospital
Moderately Bearish
4,165.001.291,940.9640.8912.110.12157.84
Gpt Healthcare
Moderately Bearish
158.000.861,299.7926.155.841.298.68
Shalby Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Shalby is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 74.27%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.72 percentage points from previous quarter
    • InsightsMutual Funds are not invested in this company.
    Shalby Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-03Quarterly Results & Others
    2024-10-30Quarterly Results
    2024-07-08Quarterly Results
    2024-05-28Audited Results & Final Dividend
    2024-02-07Quarterly Results
    About the company Shalby
    • IndustryHealthcare Facilities
    • ISININE597J01018
    • BSE Code540797
    • NSE CodeSHALBY
    Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company operate through three main verticals: hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise and implant business. The Company is engaged in the arthroplasty segment. It has its presence across tertiary and quaternary specialties including cardiology, neurology, oncology and cardiac. SOCE offers a comprehensive orthopedic center with easy access and treatment for all orthopedic-related issues, including joint replacement surgery, at affordable rates. The Company encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and more.
    • Management Info
    • Vikram ShahChairman of the Board, Managing Director
    • Amit PathakChief Financial Officer
    • Deepak AnanthakrishnanGlobal Chief Business Officer
    • Shanay ShahDesignated Director of International Business
    • Tushar ShahCompany Secretary, Associate Vice President
    Shalby Share Price FAQs

    Shalby is trading at 191.15 as on Wed May 14 2025 09:59:48. This is -0.23% lower as compared to its previous closing price of 191.60.

    The market capitalization of Shalby is 2060.84 Cr as on Wed May 14 2025 09:59:48.

    The average broker rating on Shalby is Buy. The breakup of analyst rating is given below -

    • 0.00 analysts have given a strong buy rating
    • 1 analysts have given a buy rating
    • 0.00 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Shalby is 325.00 whereas the 52 wk low is 177.25

    Shalby can be analyzed on the following key metrics -

    • TTM P/E: 77.41
    • Sector P/E: 23.64
    • Dividend Yield: 0.63%
    • D/E ratio: -

    Shalby reported a net profit of 84.08 Cr in 2024.